Miller DS - Search Results

1

Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer.

Schorge JO, Drake RD, Lee H, Skates SJ, Rajanbabu R, Miller DS, Kim JH, Cramer DW, Berkowitz RS, Mok SC. Schorge JO, et al. Among authors: miller ds. Clin Cancer Res. 2004 May 15;10(10):3474-8. doi: 10.1158/1078-0432.CCR-03-0365. Clin Cancer Res. 2004. PMID: 15161704

2

Critical reassessment of second-look exploratory laparotomy for epithelial ovarian carcinoma. Minimal diagnostic and therapeutic value in patients with persistent cancer.

Miller DS, Spirtos NM, Ballon SC, Cox RS, Soriero OM, Teng NN. Miller DS, et al. Cancer. 1992 Jan 15;69(2):502-10. doi: 10.1002/1097-0142(19920115)69:2<502::aid-cncr2820690238>3.0.co;2-4. Cancer. 1992. PMID: 1728381

3

Germline BRCA1-2 mutations in non-Ashkenazi families with double primary breast and ovarian cancer.

Schorge JO, Mahoney NM, Miller DS, Coleman RL, Muller CY, Euhus DM, Tomlinson GE. Schorge JO, et al. Among authors: miller ds. Gynecol Oncol. 2001 Nov;83(2):383-7. doi: 10.1006/gyno.2001.6431. Gynecol Oncol. 2001. PMID: 11606101

4

Stage IIB-IVB cervical adenocarcinoma: prognostic factors and survival.

Lea JS, Sheets EE, Wenham RM, Duska LR, Coleman RL, Miller DS, Schorge JO. Lea JS, et al. Among authors: miller ds. Gynecol Oncol. 2002 Jan;84(1):115-9. doi: 10.1006/gyno.2001.6473. Gynecol Oncol. 2002. PMID: 11748986

5

Early-stage cervical adenocarcinoma treated by surgical intent: the role of para-aortic lymph node dissection.

Lea JS, Sheets EE, Duska LR, Miller DS, Schorge JO. Lea JS, et al. Among authors: miller ds. Gynecol Oncol. 2002 Feb;84(2):285-8. doi: 10.1006/gyno.2001.6524. Gynecol Oncol. 2002. PMID: 11812088

6

Endocervical curettage at conization to predict residual cervical adenocarcinoma in situ.

Lea JS, Shin CH, Sheets EE, Coleman RL, Gehrig PA, Duska LR, Miller DS, Schorge JO. Lea JS, et al. Among authors: miller ds. Gynecol Oncol. 2002 Oct;87(1):129-32. doi: 10.1006/gyno.2002.6791. Gynecol Oncol. 2002. PMID: 12468353

7

Cervical adenocarcinoma survival among Hispanic and white women: a multicenter cohort study.

Schorge JO, Lea JS, Garner EO, Duska LR, Miller DS, Coleman RL. Schorge JO, et al. Among authors: miller ds. Am J Obstet Gynecol. 2003 Mar;188(3):640-4. doi: 10.1067/mob.2003.96. Am J Obstet Gynecol. 2003. PMID: 12634634

8

Postmolar surveillance at a trophoblastic disease center that serves indigent women.

Allen JE, King MR, Farrar DF, Miller DS, Schorge JO. Allen JE, et al. Among authors: miller ds. Am J Obstet Gynecol. 2003 May;188(5):1151-3. doi: 10.1067/mob.2003.297. Am J Obstet Gynecol. 2003. PMID: 12748460

9

Management of low-risk gestational trophoblastic neoplasia in indigent women.

Schorge JO, Lea JS, Farrar DF, King MR, Coleman RL, Miller DS. Schorge JO, et al. Among authors: miller ds. J Reprod Med. 2003 Oct;48(10):780-4. J Reprod Med. 2003. PMID: 14628732

10

Adenosquamous histology predicts poor outcome in low-risk stage IB1 cervical adenocarcinoma.

Lea JS, Coleman RL, Garner EO, Duska LR, Miller DS, Schorge JO. Lea JS, et al. Among authors: miller ds. Gynecol Oncol. 2003 Dec;91(3):558-62. doi: 10.1016/j.ygyno.2003.08.020. Gynecol Oncol. 2003. PMID: 14675676

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

729 results

Search Page

Filters